Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|September 23, 2018
Transient Gene Expression in Suspension HEK293-EBNA1 CellsDenis L'Abbé, Louis Bisson, Christian Gervais, et al.Journal of Biomolecular Screening|February 24, 2011
Development and validation of a high-throughput screening assay for the hepatitis C virus p7 viroporinChristian Gervais, Florence Dô, Ariane Cantin, et al.Journal of Biotechnology|December 10, 2020
Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cellsMatthew Stuible, Christian Gervais, Simon Lord-Dufour, et al.Biotechnology and Bioengineering|August 22, 2025
Endogenous Retrovirus-Like Particle-Deficient CHO Cells Can be Generated by CRISPR or shRNA and Enriched Based on Cell-Surface Expression of Retroviral Envelope ProteinMatthew Stuible, Sergio P Alpuche-Lazcano, Christian Gervais, et al.Glycoconjugate Journal|October 11, 2015
Preparation of legionaminic acid analogs of sialo-glycoconjugates by means of mammalian sialyltransferasesDavid C Watson, Warren W Wakarchuk, Christian Gervais, et al.Scientific Reports|October 1, 2023
Influence of variant-specific mutations, temperature and pH on conformations of a large set of SARS-CoV-2 spike trimer vaccine antigen candidatesMatthew Stuible, Joseph D Schrag, Joey Sheff, et al.Frontiers in Immunology|February 6, 2023
Assessment of the longitudinal humoral response in non-hospitalized SARS-CoV-2-positive individuals at decentralized sites: Outcomes and concordanceAbdelhadi Djaïleb, Étienne Lavallée, Megan-Faye Parker, et al.NPJ Vaccines|October 12, 2022
Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concernBassel Akache, Tyler M Renner, Matthew Stuible, et al.Scientific Reports|November 9, 2021
Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvantBassel Akache, Tyler M Renner, Anh Tran, et al.Scientific Reports|November 9, 2021
Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteinsMaryam Hojjat Jodaylami, Abdelhadi Djaïleb, Pierre Ricard, et al.Pageof 2